AzTrials
AzTrials

Physical ActivityNCT05482178

The Association of Resistance Exercise With the Inflammasome Activation in Obesity Subjects

A study testing Resistance exercise training plus hypocaloric diet and Hypocaloric diet in people with Physical Activity and Resistance Exercise, run by Elisa Barron-Cabrera at 1 site in Mexico.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The intervention study consist in 3 months of follow up to evaluate the effect of resistance exercise on NLRP3 and interleukin-18 (IL-18) gene expression, and IL-18 and IL-1b cytokines levels in obese subjects, due to, the current evidence has been suggested that aerobic physical exercise could reduce the low-grade… Read more about this study

Who is it for?
Ages 25 to 50 yearsHealthy volunteers can take part
What is being tested?
Resistance exercise training plus hypocaloric diet and Hypocaloric diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteMexico
Study dates
31 May 2022to 16 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Both sex
  • Older than 25 years old
  • Women with waist circumference ≥ 80cm and men with ≥ 90cm
  • Subjects with BMI between 30 and 40 kg/m2

Who cannot join

  • Subjects with diagnosis of metabolic alterations
  • Subjects with chronic pharmacological treatment
  • Subjects with anti-inflammatories drugs prescription

Trial locations and contacts

1 site in 1 country.

Melissa Vega, PhD contact

+526677545353

melissa.vega@uas.edu.mx

Marcela Vergara, PhD contact

+526677545353

mjvergara@uas.edu.mx

Mexico1 site, 1 recruiting
  • Autonomous University of Sinaloa

    Culiacán, Sinaloa, 80019

    Elisa Barron, PhD, +526677556059, elisabarron@uas.edu.mx

    Recruiting

Other trials in Mexico

About this study

Official title: The Potential Role of Resistance Exercise on Inflammasome Activation and Cytokines Levels in Obese Subjects

The intervention study consist in 3 months of follow up to evaluate the effect of resistance exercise on NLRP3 and interleukin-18 (IL-18) gene expression, and IL-18 and IL-1b cytokines levels in obese subjects, due to, the current evidence has been suggested that aerobic physical exercise could reduce the low-grade chronic inflammation through the downregulation of the NLRP3 inflammasome in obesity subjects, however, there are not enough evidence with resistance protocol. The investigator randomized into two intervention groups: a) group with resistance exercise training plus hypocaloric diet, and b) group with hypocaloric diet. The blood sample was taken fasting at baseline and final intervention (3rd month). The serum was separated for biochemical analyzes and the quantification of cytokines levels. The RNA was obtained from leukocytes to expression assay.

Read the detailed description

Obesity is a metabolic condition with a high worldwide prevalence. It is characterized by low-grade chronic inflammation and high cytokines level as consequence of the excessive accumulation of adipose tissue. The NLRP3 protein is part of the NLRP3 inflammasome, a multiprotein complex related to inflammation and the risk of developing metabolic disorders. In this sense, the evidence has been suggested that physical exercise could reduce the inflammation through the downregulation of the NLRP3 inflammasome. The aim of this study is evaluate the effect of resistance exercise on NLRP3 and IL-18 gene expression and and IL-18 and IL-1b cytokines levels in obese subjects. This is an experimental study with 3 months of follow up. Participants were randomized into two intervention groups: a) group with resistance exercise plus hypocaloric diet, and b) group with hypocaloric diet. The exercise program was design by certified personal trained, and consisted in 3 phases: conditioning, development and maintenance. Dietary information was collect by validated retrospective questionnaires (24-hour record and 3-days dietary diary) and analyzed in Nutritionist Pro software. Body composition was evaluated by bioimpedance. The biochemical analyzes were performed on serum sample using spectrophotometry equipment. RNA was obtained from leukocytes from peripheral blood, cDNA synthesis was performed with a ThermoFisher kit, and the expression assay was performed by real-time polymerase chain reaction (PCR) using Taqman probes with the 2-ΔΔcq relative quantification method. Cytokines quantification were perform using a commercial ELISA kit. Statistical analysis will be using the Statistical Package for Social Sciences (SPSS v.25) software and a value of p<0.05 will be considered statistically significant.

Being tested
Resistance exercise training plus hypocaloric diet, Hypocaloric diet
Keywords
Resistance training, inflammasome, Obesity
Medical subject headings
Motor Activity, Inflammation, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resistance exercise training plus hypocaloric dietBehavioural

    The exercise program included 3 phases of progressive intervention: 1) Adaptation which included 3-4 days per week at 60% of maximum heart rate, 2) Development phase which included 5 days per week at 75-85% of maximum heart rate and the last one, 3) Maintenance phase which included 5 days per week at 75-90% of maximum heart rate. The control and follow up will be through text message exchanges at least once a week or as many as necessary.

    On the other hand, the diet intervention consisted a caloric restriction of 20% of total energy estimated with Mifflin formula. The nutrients distributions are 50% for carbohydrates, 20% for protein and 30% for lipids, ensuring a sufficient intake of fiber (>25g per day).

  • Hypocaloric dietBehavioural

    The diet intervention consisted a caloric restriction of 20% of total energy estimated with Mifflin formula. The nutrients distributions are 50% for carbohydrates, 20% for protein and 30% for lipids, ensuring a sufficient intake of fiber (>25g per day).

Study groups in NCT05482178
Study groupRoleWhat they receive
Resistance exercise training plus hypocaloric dietExperimentalThe participants received a caloric restriction of 20% of total energy estimated with Mifflin formula plus a structured, planned, and controlled resistance exercise program by a personal trained. The participant received the exercise program instructions every week and they performed by the own, and record the heart rate of each session on a paper format. All the appointment were once a month by trained nutritionists, and all the participants received a nutritional recommendation for the obesity management and a balanced food plan.
Receives: Behavioral: Resistance exercise training plus hypocaloric diet
Hypocaloric dietActive comparatorThe participants received a caloric restriction of 20% of total energy estimated with Mifflin formula. All the appointment were once a month by trained nutritionists, and all the subjects received a nutritional recommendation for the obesity management and a balanced food plan.
Receives: Behavioral: Hypocaloric diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. NLRP3 gene expression

    Assay expression will be performed by real-time PCR using Taqman probes with the 2-ΔΔcq relative quantification method

    Measured: Change from baseline NLRP3 gene expression at 3 months

  2. IL-18 gene expression

    Assay expression will be performed by real-time PCR using Taqman probes with the 2-ΔΔcq relative quantification method

    Measured: Change from baseline IL-18 gene expression at 3 months

  3. IL-18 cytokine

    commercial ELISA kit

    Measured: Change from baseline IL-18 cytokine at 3 months

  4. IL-1b cytokine

    commercial ELISA kit

    Measured: Change from baseline IL-1b cytokine at 3 months

Secondary outcomes (5)
  1. Weight

    Weighing machine using bioimpedance technology

    Measured: Change from baseline weight at 3 months

  2. Body fat mass

    Weighing machine using bioimpedance technology

    Measured: Change from baseline body fat mass at 3 months

  3. Serum triglycerides

    Liquid chemistry using spectrum equipment

    Measured: Change from baseline serum triglycerides at 3 months

  4. Serum cholesterol

    Liquid chemistry using spectrum equipment

    Measured: Change from baseline serum cholesterol at 3 months

  5. Serum glucose

    Liquid chemistry using spectrum equipment

    Measured: Change from baseline serum glucose at 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Aug 2022
  2. Study start31 May 2022
  3. Primary completion15 Aug 2022 (estimated)
  4. Study completion16 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Experimental
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05482178
Sponsor's protocol ID
CE-FCNYG-2022-FEB-001
Status last verified
Jul 2022
First submitted
27 Jul 2022
Last updated
1 Aug 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: We reserve to respect the individual rights of not revealing personal data of the participants, since this information is signing in the informed consent. However, we will publish all the results on a manuscript.

Publications

  • Metsios GS, Moe RH, Kitas GD. Exercise and inflammation. Best Pract Res Clin Rheumatol. 2020 Apr;34(2):101504. doi: 10.1016/j.berh.2020.101504. Epub 2020 Apr 2.

    PubMed 32249021
  • Izaola O, de Luis D, Sajoux I, Domingo JC, Vidal M. [Inflammation and obesity (lipoinflammation)]. Nutr Hosp. 2015 Jun 1;31(6):2352-8. doi: 10.3305/nh.2015.31.6.8829. Spanish.

    PubMed 26040339
  • Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res. 2015 Jan 16;8:15-27. doi: 10.2147/JIR.S51250. eCollection 2015.

    PubMed 25653548
  • You T, Berman DM, Ryan AS, Nicklas BJ. Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women. J Clin Endocrinol Metab. 2004 Apr;89(4):1739-46. doi: 10.1210/jc.2003-031310.

    PubMed 15070939
  • Barron-Cabrera E, Gonzalez-Becerra K, Rosales-Chavez G, Mora-Jimenez A, Hernandez-Canaveral I, Martinez-Lopez E. Low-grade chronic inflammation is attenuated by exercise training in obese adults through down-regulation of ASC gene in peripheral blood: a pilot study. Genes Nutr. 2020 Aug 27;15(1):15. doi: 10.1186/s12263-020-00674-0.

    PubMed 32854610
  • Butts B, Butler J, Dunbar SB, Corwin E, Gary RA. Effects of Exercise on ASC Methylation and IL-1 Cytokines in Heart Failure. Med Sci Sports Exerc. 2018 Sep;50(9):1757-1766. doi: 10.1249/MSS.0000000000001641.

    PubMed 29683921
  • Nakajima K, Takeoka M, Mori M, Hashimoto S, Sakurai A, Nose H, Higuchi K, Itano N, Shiohara M, Oh T, Taniguchi S. Exercise effects on methylation of ASC gene. Int J Sports Med. 2010 Sep;31(9):671-5. doi: 10.1055/s-0029-1246140. Epub 2010 Mar 3.

    PubMed 20200803

Questions about this trial

What is this clinical trial studying?

A study testing Resistance exercise training plus hypocaloric diet and Hypocaloric diet in people with Physical Activity and Resistance Exercise, run by Elisa Barron-Cabrera at 1 site in Mexico.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Melissa Vega, PhD (+526677545353, melissa.vega@uas.edu.mx), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

NLRP3 gene expression (time frame: Change from baseline NLRP3 gene expression at 3 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05482178, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in